Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Savara Inc (SVRA)

Savara Inc (SVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 554,329
  • Shares Outstanding, K 171,619
  • Annual Sales, $ 0 K
  • Annual Income, $ -54,700 K
  • EBIT $ -90 M
  • EBITDA $ -94 M
  • 60-Month Beta 0.92
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.67

Options Overview Details

View History
  • Implied Volatility 213.10% ( -47.01%)
  • Historical Volatility 76.57%
  • IV Percentile 85%
  • IV Rank 41.25%
  • IV High 500.46% on 06/24/24
  • IV Low 11.35% on 08/12/24
  • Put/Call Vol Ratio 6.76
  • Today's Volume 132
  • Volume Avg (30-Day) 63
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 1,998
  • Open Int (30-Day) 1,762

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.11
  • Number of Estimates 4
  • High Estimate -0.10
  • Low Estimate -0.12
  • Prior Year -0.09
  • Growth Rate Est. (year over year) -22.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.99 +8.03%
on 12/18/24
3.83 -15.56%
on 12/06/24
+0.10 (+3.19%)
since 11/20/24
3-Month
2.82 +14.74%
on 11/18/24
4.70 -31.28%
on 09/23/24
-1.26 (-28.06%)
since 09/20/24
52-Week
2.82 +14.74%
on 11/18/24
5.70 -43.33%
on 03/05/24
-1.29 (-28.54%)
since 12/20/23

Most Recent Stories

More News
Insider Sale: CHIEF EXECUTIVE OFFICER of $SVRA (SVRA) Sells 54,702 Shares

Matthew Pauls, the CHIEF EXECUTIVE OFFICER of $SVRA ($SVRA), sold 54,702 shares of the company on 12-16-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.4%...

SVRA : 3.23 (unch)
Insider Purchase: Director at $SVRA (SVRA) Buys 20,000 Shares

Joseph S McCracken, a director at $SVRA ($SVRA), bought 20,000 shares of the company on 11-19-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their...

SVRA : 3.23 (unch)
Stocks Set to Open Higher as Investors Await U.S. Inflation Data

September S&P 500 E-Mini futures (ESU24) are up +0.74%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.95% this morning, partially rebounding from Friday’s losses driven by weaker-than-expected...

ESU24 : 5,699.99s (-0.31%)
NQU24 : 19,808.01s (-0.21%)
AVGO : 220.79 (+1.13%)
TSLA : 421.06 (-3.46%)
AMZN : 224.92 (+0.73%)
SMCI : 31.59 (+1.12%)
IOT : 44.32 (+3.87%)
ADBE : 447.17 (+2.24%)
ORCL : 169.66 (+0.52%)
KR : 61.85 (+1.46%)
GME : 29.82 (+2.83%)
ADS.D.DX : 236.500 (+0.02%)
Why Shares of Savara Jumped on Tuesday

The company released first-quarter earnings and said it had completed a phase 3 trial enrollment for its lead therapy.

SVRA : 3.23 (unch)
Savara Announces New Employment Inducement Grant

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to two new employees.

SVRA : 3.23 (unch)
Savara Announces New Employment Inducement Grant

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to two new employees.

SVRA : 3.23 (unch)
Savara Reports Fourth Quarter / Year-End 2022 Financial Results and Provides Business Update

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the fourth quarter and full year ending December 31, 2022 and...

SVRA : 3.23 (unch)
Savara to Present at the Oppenheimer 33rd Annual Healthcare Conference

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the Oppenheimer 33rd Annual Healthcare...

SVRA : 3.23 (unch)
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to a new employee.

SVRA : 3.23 (unch)
Savara Announces New Leadership Appointments

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the appointments of two pharmaceutical industry veterans to its executive leadership...

SVRA : 3.23 (unch)

Business Summary

Savara Inc. is a clinical-stage pharmaceutical company. It focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Savara Inc., formerly known as Mast Therapeutics, Inc., is based in Austin, United States.

See More

Key Turning Points

3rd Resistance Point 3.54
2nd Resistance Point 3.43
1st Resistance Point 3.33
Last Price 3.23
1st Support Level 3.13
2nd Support Level 3.02
3rd Support Level 2.92

See More

52-Week High 5.70
Fibonacci 61.8% 4.60
Fibonacci 50% 4.26
Fibonacci 38.2% 3.92
Last Price 3.23
52-Week Low 2.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar